SmartCella strengthens team with Dr Ricardo Baptista as CTO [Yahoo! Finance]
Cellectis S.A. - American Depositary Shares (CLLS)
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cellectis.com/en/investors
Company Research
Source: Yahoo! Finance
Ricardo is an experienced Biochemical Engineer with almost 20-years of global experience in the medical biotechnology industry. He has a significant track record of leading technical teams at key cell and gene therapy companies, globally. Ricardo will be a member of SmartCella's Executive Management Team and be based in Stockholm head office. SmartCella is an innovative biotechnology company developing stem cell and RNA-based therapies in combination with novel delivery devices such as the FDA-cleared Extroducer. With Ricardo Baptista onboard, SmartCella takes the next step on its growth and development journey by further strengthening its scientific competencies. With critical infrastructure and capabilities in place, a top talented team as well as a substantial pipeline of projects, SmartCella is well positioned to create value for both shareholders and patients in need. Niklas Prager , CEO of SmartCella, says: "The appointment of Ricardo as CTO and Head of Procella is yet anoth
Show less
Read more
Impact Snapshot
Event Time:
CLLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLLS alerts
High impacting Cellectis S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
CLLS
News
- Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 [Yahoo! Finance]Yahoo! Finance
- Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023GlobeNewswire
- Cellectis S.A. (NASDAQ: CLLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs [Yahoo! Finance]Yahoo! Finance
- Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCsGlobeNewswire
CLLS
Earnings
- 11/6/23 - In-Line
CLLS
Sec Filings
- 4/29/24 - Form 20-F
- 4/22/24 - Form 6-K
- 4/10/24 - Form 6-K
- CLLS's page on the SEC website